Page 3 - தொடர்புடையது மருத்துவமனையில் அனுமதித்தல் கண்காணிப்பு வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory.

United statesSilviu itescuKristen bothwellPaul hughesCenters for diseaseYork heart associationUnited states food drug administrationPharmaceuticals coAustralian securities exchangeSurgcenter developmentOffice of tissueHospitalization surveillance networkMesoblast limited nasdaqCorporate communications investorsChief executiveUnited states food